Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Amino Acid derivatives as new zinc binding groups for the design of selective matrix metalloproteinase inhibitors.
[Neuroimmunology: theoretical and clinical aspects].
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar.
RA: from risk factors and pathogenesis to prevention: Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.
Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
Seropositive Neuromyelitis Optica: A Pediatric Case Report and 6-Year Follow-Up.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study.
B Cells Promote Induction of Experimental Autoimmune Encephalomyelitis by Facilitating Reactivation of T Cells in the Central Nervous System.
Revised diagnostic criteria of multiple sclerosis.
Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy.
Axonal Damage in Pediatric Multiple Sclerosis.
Data collection capabilities of a new non-invasive monitoring system for patients with advanced multiple sclerosis.
Effect of seasonal fluctuation of ambient temperature on fatigue in multiple sclerosis patients living in Attica, Greece.
Merck Loses Protection for Patent on Zocor
B cells in Multiple Sclerosis: Good or bad guys?: An article for 28 May 2014 - World MS Day 2014.
Current standards of treatment in ms and the role of oral agents.
Low levels of vitamin d in neuromyelitis optica spectrum disorder: association with disease disability.
Enriched CD161high CCR6+ γδ T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis.
An observational study of venoplasty in patients with multiple sclerosis.
TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
480
481
482
483
484
485
486
487
488
…
next ›
last »